Matched sibling donors versus alternative donors in allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia in México

References

• Young NS. Aplastic anaemia. Lancet 1995;346(8969):228–32.
   PubMedGoogle Scholar
• Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A, et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2007;92(1):11–8.
   PubMed Web of Science ®Google Scholar
• Storb R, Blume KG, O'Donnell MR, Chauncey T, Forman SJ, Deeg HJ, et al. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2001;7(1):39–44.
   PubMed Web of Science ®Google Scholar
• Yoshida N, Yagasaki H, Hama A, Takahashi Y, Kosaka Y, Kobayashi R, et al. Predicting response to immunosuppressive therapy in childhood aplastic anemia. Haematologica 2011;96(5):771–4.
   PubMed Web of Science ®Google Scholar
• Fuhrer M, Rampf U, Baumann I, Faldum A, Niemeyer C, Janka-Schaub G, et al. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood 2005;106(6):2102–04.
   PubMed Web of Science ®Google Scholar
• Pongtanakul B, Das PK, Charpentier K, Dror Y. Outcome of children with aplastic anemia treated with immunosuppressive therapy. Pediatr Blood Cancer 2008;50(1):52–7.
   PubMed Web of Science ®Google Scholar
• Korthof ET, Bekassy AN, Hussein AA. Management of acquired aplastic anemia in children. Bone Marrow Transplant. 2013;48(2):191–5.
   PubMed Web of Science ®Google Scholar
• Chen J, Lee V, Luo CJ, Chiang AK, Hongeng S, Tan PL, et al. Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group. Br J Haematol. 2013;162(3):383–91.
   PubMed Web of Science ®Google Scholar
• Kennedy-Nasser AA, Leung KS, Mahajan A, Weiss HL, Arce JA, Gottschalk S, et al. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2006;12(12):1277–84.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Socie G, Lanino E, Prete A, Locatelli F, Locasciulli A, et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica 2010;95(6):976–82.
   PubMed Web of Science ®Google Scholar
• Perez-Albuerne ED, Eapen M, Klein J, Gross TJ, Lipton JM, Baker KS, et al. Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia. Br J Haematol. 2008;141(2):216–23.
   PubMed Web of Science ®Google Scholar
• Yagasaki H, Takahashi Y, Hama A, Kudo K, Nishio N, Muramatsu H, et al. Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia. Bone Marrow Transplant. 2010;45(10):1508–13.
   PubMed Web of Science ®Google Scholar
• Hsieh MY, Chiou TJ, Hung GY, Yen HJ. Outcomes of matched sibling and alternative donor stem cell transplantation for 26 children with severe aplastic anemia. Int J Hematol. 2010;91(1):54–60.
   PubMed Web of Science ®Google Scholar
• Samarasinghe S, Steward C, Hiwarkar P, Saif MA, Hough R, Webb D, et al. Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience. Br J Haematol. 2012;157(3):339–46.
   PubMed Web of Science ®Google Scholar
• Benitez-Aranda H, Velez-Ruelas MA, Diaz-Cardenas S, Sanchez-Valle E, Xolotl-Castillo M, Duenas-Gonzalez MT, et al. Incidence of aplastic anemia in a defined subpopulation from Mexico City. Hematology 2002;7(4):229–32.
   PubMedGoogle Scholar
• Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H, German Aplastic Anemia Study G. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 2003;101(4):1236–42.
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Bruno B, Rambaldi A, Saracco P, Dufour C, Finelli C, et al. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study. Haematologica 2004;89(9):1054–61.
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Arcese W, Locatelli F, Di Bona E, Bacigalupo A, Italian Aplastic Anaemia Study G. Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. Lancet 2001;357(9249):43–4.
   PubMed Web of Science ®Google Scholar
• Kojima S, Ohara A, Tsuchida M, Kudoh T, Hanada R, Okimoto Y, et al. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 2002;100(3):786–90.
   PubMed Web of Science ®Google Scholar
• Szpecht D, Gorczynska E, Kalwak K, Owoc-Lempach J, Choma M, Styczynski J, et al. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation. Arch Immunol Ther Exp. 2012;60(3):225–33.
   PubMed Web of Science ®Google Scholar
• Srinivasan R, Takahashi Y, McCoy JP, Espinoza-Delgado I, Dorrance C, Igarashi T, et al. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol. 2006;133(3):305–14.
   PubMed Web of Science ®Google Scholar
• Burroughs LM, Woolfrey AE, Storer BE, Deeg HJ, Flowers ME, Martin PJ, et al. Success of allogeneic marrow transplantation for children with severe aplastic anaemia. Br J Haematol. 2012;158(1):120–8.
   PubMed Web of Science ®Google Scholar
• Kim H, Lee JH, Joo YD, Bae SH, Hyun MS, Lee JH, et al. A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome. Ann Hematol. 2012;91(9):1459–69.
   PubMed Web of Science ®Google Scholar
• Chung NG, Lee JW, Jang PS, Jeong DC, Cho B, Kim HK. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia. Pediatr Transplant. 2013;17(4):387–93.
   PubMed Web of Science ®Google Scholar
• Kikuchi A, Yabe H, Kato K, Koh K, Inagaki J, Sasahara Y, et al. Long-term outcome of childhood aplastic anemia patients who underwent allogeneic hematopoietic SCT from an HLA-matched sibling donor in Japan. Bone Marrow Transplant. 2013;48(5):657–60.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Socie G, Schrezenmeier H, Tichelli A, Locasciulli A, Fuehrer M, et al. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica 2012;97(8):1142–8.
   PubMed Web of Science ®Google Scholar
• Eapen M, Horowitz MM. Alternative donor transplantation for aplastic anemia. Hematol Am Soc Hematol Educ Program 2010;2010:43–6.
   PubMedGoogle Scholar
• MacMillan ML, Walters MC, Gluckman E. Transplant outcomes in bone marrow failure syndromes and hemoglobinopathies. Semin Hematol. 2010;47(1):37–45.
   PubMed Web of Science ®Google Scholar
• Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y, et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2008;14(9):1057–63.
   PubMed Web of Science ®Google Scholar
• Yagasaki H, Kojima S, Yabe H, Kato K, Kigasawa H, Sakamaki H, et al. Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia. Blood 2011;118(11):3186–90.
   PubMed Web of Science ®Google Scholar